Prospective Flutemetamol Positron Emission Tomography and Histopathology in Normal Pressure Hydrocephalus
Authors:
- Janek FrantzenJFJanek Frantzen
- Ville LeinonenVLVille Leinonen
- Kimmo LonnrotKLKimmo Lonnrot
- Aki LaaksoALAki Laakso
- Kirsi A. VirtanenKVKirsi A. Virtanen
- Olof SolinOSOlof Solin
- Anna KotkansaloAKAnna Kotkansalo
- Anne KoivistoAKAnne Koivisto
- Juha SajantiJSJuha Sajanti
- Atte KarppinenAKAtte Karppinen
- Hanna LehtoHLHanna Lehto
- 27 November 2013
- journal article
- research article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 13 (4) , 237-245
Abstract
Backgound/Objective: To determine the level of association between uptake of the amyloid positron emission tomography (PET) imaging agent [18F]flutemetamol and the level of amyloid-ß measured by immunohistochemical and histochemical staining in a frontal cortical region biopsy site. Methods: Seventeen patients with probable normal pressure hydrocephalus (NPH) underwent prospective [18F]flutemetamol PET and subsequent frontal cortical brain biopsy during ventriculoperitoneal shunting. Tissue amyloid-ß was evaluated using the monoclonal antibody 4G8, thioflavin S and Bielschowsky silver stain. Results: Four of the 17 patients (23.5%) had amyloid-ß pathology based on the overall pathology read and also showed increased [18F]flutemetamol uptake. [18F]Flutemetamol standardized uptake values from the biopsy site were significantly associated with biopsy specimen amyloid-ß levels (Pearson's r = 0.67; p = 0.006). There was also good correlation between the biopsy specimen amyloid-ß level and uptake of [18F]flutemetamol in the region contralateral to the biopsy site (r = 0.67; p = 0.006), as well as with composite cortical [18F]flutemetamol uptake (r = 0.65; p = 0.008). The blinded visual read showed a high level of agreement between all readers (κ = 0.88). Two of 3 readers were in full agreement on all images; 1 reader disagreed on 1 of the 17 NPH cases. Blinded visual assessments of PET images by 1 reader were associated with 100% sensitivity to the overall pathology read, and assessments by the 2 others were associated with 75% sensitivity (overall sensitivity by majority read was 75%); specificity of all readers was 100%. Conclusions: [18F]Flutemetamol detects brain amyloid-ß in vivo and shows promise as a valuable tool to study and possibly facilitate diagnosis of Alzheimer's disease both in patients with suspected NPH and among the wider population.Keywords
This publication has 25 references indexed in Scilit:
- Poor Cognitive Outcome in Shunt-Responsive Idiopathic Normal Pressure HydrocephalusNeurosurgery, 2013
- Technical aspects of amyloid imaging for Alzheimer's diseaseAlzheimer's Research & Therapy, 2011
- Amyloid and tau proteins in cortical brain biopsy and Alzheimer's diseaseAnnals of Neurology, 2010
- Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathologyAnnals of Neurology, 2010
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseBrain, 2009
- Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound BJournal of Neuroscience Methods, 2008
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseBrain, 2008
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBrain, 2008
- Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt responseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- An evaluation of current methods for the diagnostic histochemistry of amyloidJournal of Clinical Pathology, 1969